Altrius Capital Management Inc lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 46,609 shares of the biopharmaceutical company’s stock after purchasing an additional 1,785 shares during the […]